- Home
- SHLT vs SRZN Comparison
SHLT vs SRZN Comparison
Compare SHLT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- SRZN
- Stock Information
- Founded
- SHLT 1987
- SRZN 2015
- Country
- SHLT Israel
- SRZN United States
- Employees
- SHLT N/A
- SRZN N/A
- Industry
- SHLT Business Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- SHLT Consumer Discretionary
- SRZN Health Care
- Exchange
- SHLT Nasdaq
- SRZN Nasdaq
- Market Cap
- SHLT 46.9M
- SRZN 38.1M
- IPO Year
- SHLT N/A
- SRZN N/A
- Fundamental
- Price
- SHLT $2.72
- SRZN $11.13
- Analyst Decision
- SHLT Strong Buy
- SRZN Strong Buy
- Analyst Count
- SHLT 1
- SRZN 2
- Target Price
- SHLT $11.00
- SRZN $38.50
- AVG Volume (30 Days)
- SHLT 3.3K
- SRZN 39.5K
- Earning Date
- SHLT 09-26-2024
- SRZN 11-06-2024
- Dividend Yield
- SHLT N/A
- SRZN N/A
- EPS Growth
- SHLT N/A
- SRZN N/A
- EPS
- SHLT N/A
- SRZN N/A
- Revenue
- SHLT $55,939,000.00
- SRZN $10,000,000.00
- Revenue This Year
- SHLT N/A
- SRZN N/A
- Revenue Next Year
- SHLT N/A
- SRZN N/A
- P/E Ratio
- SHLT N/A
- SRZN N/A
- Revenue Growth
- SHLT N/A
- SRZN N/A
- 52 Week Low
- SHLT $2.54
- SRZN $6.00
- 52 Week High
- SHLT $7.96
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- SHLT 39.44
- SRZN 45.02
- Support Level
- SHLT $2.71
- SRZN $10.55
- Resistance Level
- SHLT $2.85
- SRZN $13.34
- Average True Range (ATR)
- SHLT 0.11
- SRZN 1.25
- MACD
- SHLT -0.01
- SRZN -0.15
- Stochastic Oscillator
- SHLT 0.00
- SRZN 22.61
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).